These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1041216)

  • 21. Comparative in vitro evaluation of the effects of ticarcillin and carbenicillin upon Psuedomonas aeruginosa.
    Kalkani E; Marketos N
    Antimicrob Agents Chemother; 1976 Jan; 9(1):89-90. PubMed ID: 816248
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ticarcillin, carbenicillin and BL-P1908. In vitro comparison of three anti-pseudomonal semisynthetic penicillins.
    Fuchs PC; Thornsberry C; Barry AL; Gavan TL; Gerlach EH; Jones RN
    J Antibiot (Tokyo); 1977 Dec; 30(12):1098-106. PubMed ID: 599083
    [No Abstract]   [Full Text] [Related]  

  • 23. Evaluation of BL-P1654: a semisynthetic penicillin as a topical ocular therapy.
    Cagle GD; Schlech BA
    Cornea; 1984; 3(1):27-32. PubMed ID: 6100241
    [TBL] [Abstract][Full Text] [Related]  

  • 24. In vitro susceptibility of pseudomonas to four beta-lactamantibiotics (ampicillin, cephalothin, carbenicillin, piperacillin), to four aminoglycosides (kanamycin, amikacin, gentamicin, tobramycin) and to colimycin.
    Hoogkamp-Korstanje JA; Westerdaal NA
    Chemotherapy; 1979; 25(1):48-53. PubMed ID: 253637
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Activities of oral and parenteral agents against penicillin-susceptible and -resistant pneumococci.
    Pankuch GA; Visalli MA; Jacobs MR; Appelbaum PC
    Antimicrob Agents Chemother; 1995 Jul; 39(7):1499-504. PubMed ID: 7492093
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Interpretation of diffusion susceptibility data obtained with 50-mu g carbenicillin discs against gram-negative organisms.
    Traub WH; Raymond EA
    Appl Microbiol; 1971 Nov; 22(5):862-4. PubMed ID: 5210841
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Selection of variants of Pseudomonas aeruginosa resistant of Beta-lactam antibiotics.
    Gwynn MN; Rolinson GN
    Infection; 1980; 8(2):73-80. PubMed ID: 6771215
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vitro activity of p-hydroxybenzyl penicillin (penicillin X) and five other penicillins against Neisseria gonorrhoeae: comparisons of strains from patients with uncomplicated infections and from women with pelvic inflammatory disease.
    Sackel SG; Alpert S; Rosner B; McCormack WM; Finland M
    Antimicrob Agents Chemother; 1977 Jul; 12(1):31-6. PubMed ID: 407840
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro activity of carbenicillin, ticarcillin, sisomicin and netilmicin alone and in combination against Pseudomonas aeruginosa.
    Watanakunakorn C; Glotzbecker C
    Chemotherapy; 1978; 24(6):343-6. PubMed ID: 100282
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Production of beta-lactamase for carbenicillin in 30 strains of Pseudomonas aeruginosa (detection of a highly resistant strain)].
    Michel-Briand Y; Bruand L
    C R Acad Hebd Seances Acad Sci D; 1972 Jul; 275(3):503-6. PubMed ID: 4628320
    [No Abstract]   [Full Text] [Related]  

  • 31. In vitro activity of carbenicillin against gram-negative bacilli.
    Bodey GP; Terrell LM
    J Bacteriol; 1968 May; 95(5):1587-90. PubMed ID: 4870276
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Piperacillin (T-1220), a new semisynthetic penicillin: in vitro antimicrobial activity comparison with carbenicillin, ticarcillin, ampicillin, cephalothin, cefamandole and cefoxitin.
    Jones RN; Thornsberry C; Barry AL; Fuchs PC; Gavan TL; Gerlach EH
    J Antibiot (Tokyo); 1977 Dec; 30(12):1107-14. PubMed ID: 599084
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Susceptibility of Pseudomonas maltophilia to antimicrobial agents, singly and in combination.
    Felegie TP; Yu VL; Rumans LW; Yee RB
    Antimicrob Agents Chemother; 1979 Dec; 16(6):833-7. PubMed ID: 533264
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Change of resistance and resistance status of the important pathogenic bacteria species (with consideration to carbenicillin)].
    Legler F
    Med Klin; 1970 May; 65(21):1037-9. PubMed ID: 4941397
    [No Abstract]   [Full Text] [Related]  

  • 35. [In vitro examination of some new penicillin derivatives with activity against Pseudomonas aeruginosa: azlocillin, mezlocillin and piperacillin compared with carbenicillin].
    Høiby N; Bremmelgaard A; Schouenborg P
    Ugeskr Laeger; 1979 Oct; 141(41):2815-8. PubMed ID: 120049
    [No Abstract]   [Full Text] [Related]  

  • 36. Carbenicillin: activity in vitro and absorption and excretion in normal young men.
    Smith CB; Finland M
    Appl Microbiol; 1968 Nov; 16(11):1753-60. PubMed ID: 4387223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. In vitro study of clavulanic acid in combination with penicillin, amoxycillin, and carbenicillin.
    Wise R; Andrews JM; Bedford KA
    Antimicrob Agents Chemother; 1978 Mar; 13(3):389-93. PubMed ID: 122520
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sensitivity to carbenicillin and ticarcillin, and the beta-lactamases of Pseudomonas aeruginosa in the UK in 1978-79.
    King JD; Farmer T; Reading C; Sutherland R
    J Clin Pathol; 1980 Mar; 33(3):297-301. PubMed ID: 6769973
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparative in vitro activity of piribenicillin, ticarcillin, and carbenicillin against Pseudomonas aeruginosa.
    Murakawa T; Sabath LD
    Antimicrob Agents Chemother; 1977 Jan; 11(1):1-6. PubMed ID: 13704
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Enhanced killing of Pseudomonas aeruginosa by human polymorphonuclear leukocytes in presence of subinhibitory concentrations of carbenicillin and ticarcillin.
    Petit JC; Daguet GL
    Biomedicine; 1981 Feb; 34(1):29-33. PubMed ID: 6784781
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.